Genomind's Series B Round

Genomind raised a round of funding on February 08, 2017.

Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsy…

Articles about Genomind's Series B Round: